Try our corporate solution for free!
(212) 419-8294
vianny.gutierrez-cruz@statista.com

Pharmaceutical industry in Mexico - Statistics & Facts

The pharmaceutical industry is among the most important sectors worldwide — not only is it essential for the general population’s health and wellbeing, but it is also one of the most profitable businesses, reaching a global revenue of more than 1.25 trillion U.S. dollars in 2019. After Brazil, Mexico has the second largest pharmaceutical market in Latin America. With more than 11 billion units of products sold in 2019, the country’s wholesale pharmaceutical industry reached a revenue of more than 174 billion Mexican pesos, or approximately 8.4 billion U.S. dollars.

An importing industry of national priority

The pharmaceutical industry in Mexico accounts for a significant share of the country’s economy, bringing in more than 70 billion Mexican pesos in 2019. With a production value of nearly 150 billion Mexican pesos that same year, the pharmaceutical market employed almost 53 thousand people in total. Despite its significant role in the national economy, Mexico’s pharma industry relies mostly on imports. Together, the United States and Germany accounted for nearly half of the total imports. Additionally, medications consisting of mixed or unmixed products for therapeutic or prophylactic uses gathered almost two thirds of this value.

COVID-19 vaccine marathon

More than one thousand drugs and vaccines targeting the coronavirus (COVID-19) disease were in development worldwide as of February 2021. The number goes down to 17 clinical studies completed in Mexico, hoping to find a cure to the pandemic that has threatened millions of lives. With 14 candidates already launched, countries all over the world had started negotiations and acquisition of the different vaccines, along with immunization campaigns that have allowed more than 205 million doses to be administered. Thus, clinical studies have not been more important for the pharmaceutical industry. A higher spending on research and development will speed up the process of new drugs becoming available on the market, not only in the case of pandemics, but also to fight diseases that have continuously burden global public health for decades.

Key figures

The most important key figures provide you with a compact summary of the topic of "Pharmaceutical industry in Mexico" and take you straight to the corresponding statistics.

Economic importance

Research and development

Interesting statistics

In the following 6 chapters, you will quickly find the 30 most important statistics relating to "Pharmaceutical industry in Mexico".

Pharmaceutical industry in Mexico

Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!
TOP SELLER

Pharmaceutical industry in Mexico - Statistics & Facts

The pharmaceutical industry is among the most important sectors worldwide — not only is it essential for the general population’s health and wellbeing, but it is also one of the most profitable businesses, reaching a global revenue of more than 1.25 trillion U.S. dollars in 2019. After Brazil, Mexico has the second largest pharmaceutical market in Latin America. With more than 11 billion units of products sold in 2019, the country’s wholesale pharmaceutical industry reached a revenue of more than 174 billion Mexican pesos, or approximately 8.4 billion U.S. dollars.

An importing industry of national priority

The pharmaceutical industry in Mexico accounts for a significant share of the country’s economy, bringing in more than 70 billion Mexican pesos in 2019. With a production value of nearly 150 billion Mexican pesos that same year, the pharmaceutical market employed almost 53 thousand people in total. Despite its significant role in the national economy, Mexico’s pharma industry relies mostly on imports. Together, the United States and Germany accounted for nearly half of the total imports. Additionally, medications consisting of mixed or unmixed products for therapeutic or prophylactic uses gathered almost two thirds of this value.

COVID-19 vaccine marathon

More than one thousand drugs and vaccines targeting the coronavirus (COVID-19) disease were in development worldwide as of February 2021. The number goes down to 17 clinical studies completed in Mexico, hoping to find a cure to the pandemic that has threatened millions of lives. With 14 candidates already launched, countries all over the world had started negotiations and acquisition of the different vaccines, along with immunization campaigns that have allowed more than 205 million doses to be administered. Thus, clinical studies have not been more important for the pharmaceutical industry. A higher spending on research and development will speed up the process of new drugs becoming available on the market, not only in the case of pandemics, but also to fight diseases that have continuously burden global public health for decades.

Interesting statistics

In the following 6 chapters, you will quickly find the 30 most important statistics relating to "Pharmaceutical industry in Mexico".

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Vianny Gutierrez-Cruz
Vianny Gutierrez-Cruz
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Ziyan Zhang
Ziyan Zhang
Customer Relations– Contact (Asia)

Mon - Fri, 11:30am - 10pm (IST)

Contact Kisara Mizuno
Kisara Mizuno
Customer Success Manager– Contact (Asia)

Mon - Fri, 9:30am - 5:30pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Associate Director - LAC– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)